Healthy Skepticism logo = snake coiled around pen over globe Healthy Skepticism

Countering misleading drug promotion

Home | About us | Site info | Contact us | Links | Other
What's new | AdWatch | HS Int News | Library | Fora
Home - www.healthyskepticism.org > library > topics: health : Updated 23 August, 2005


Free Updates
Can we help you?


Join in

Subscribe to Healthy Skepticism Updates


If you like our work please tell others.
If not, please tell us.

Health


This page lists 142 references in the Main Healthy Skepticism Library relevant to Health.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.


HSL6666
Carroll NV, Smith JC, Berringer RA, Oestreich GL.
Evaluation of an automated system for prior authorization: a COX-2 inhibitor example.
Am J Manag Care 2006 Sep 01;12(9):501-8
http://www.ajmc.com/Article.cfm?ID=3187&CFID=3768231&CFTOKEN=45537093

HSL6668
Dormont B, Grignon M, Huber H.
Health expenditure growth: reassessing the threat of ageing.
Health Econ 2006 Sep 01;15(9):947-63
Link to source with long URL

HSL6800
Akunyili D.
Dora Akunyili: battling against counterfeit drugs. Interview by Marilynn Larkin.
Lancet Infect Dis 2006 Sep 01;6(9):554-5
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(06)70575-8

HSL6795
Ahmad K.
Abbott accused of refusing access to HIV drug.
Lancet Infect Dis 2006 Sep;6(9):547

HSL6796
Twery MJ.
The cartoon character garfield and the 'sleep well. Do well. Star sleeper' campaign.
Pediatrics 2006 Sep;118(3):1259

HSL6750
Bowron A.
Bridging the information gap in primary care.
Community Pract 2006 Aug 01;79(8):242

HSL6112
Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J.
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs.
J Clin Epidemiol 2006 Aug 01;59(8):819-28
http://linkinghub.elsevier.com/retrieve/pii/S0895-4356(06)00047-3

HSL6117
Raymond MJ, Wohrle RD, Call DR.
Assessment and promotion of judicious antibiotic use on dairy farms in Washington State.
J Dairy Sci 2006 Aug 01;89(8):3228-40
http://jds.fass.org/cgi/content/full/89/8/3228

HSL6708
Power E.
Impact of antibiotic restrictions: the pharmaceutical perspective.
Clin Microbiol Infect 2006 Aug 01;12

HSL6752
Kripalani S, Henderson LE, Chiu EY, Robertson R, Kolm P, Jacobson TA.
Predictors of medication self-management skill in a low-literacy population.
J Gen Intern Med 2006 Aug 01;21(8):852-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2006.00536.x

HSL6202
Roehr B.
Institute of Medicine report strives to reduce medication errors
BMJ 2006 Jul 29;333(7561):220
http://bmj.bmjjournals.com/cgi/content/short/333/7561/220-f?etoc%3e

HSL6204
The Practice of Reform in Health, Medicine and Science, 1500-2000
BMJ 2006 Jul 29;333(7561):266
http://bmj.bmjjournals.com/cgi/content/short/333/7561/266-a?etoc%3e

HSL6205
Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J.
Chemoprevention: Drug pricing and mortality: the case of tamoxifen.
Cancer 2006 Jul 24
Link to source with long URL

HSL5993
Smellie A, Stuart W
Testing pitfalls and summary of guidance in lipid management
BMJ 2006 Jul 8;333(7558):83-86
http://bmj.bmjjournals.com/cgi/content/short/333/7558/83?etoc

HSL6696
Robinson E.
On effective health messages.
Health Serv J 2006 Jul 6;116(6013):17

HSL6151
Rigby N.
Obesity association clarifies definitions of obesity and links with drug firms.
BMJ 2006 Jul 1;333(7557):44
http://bmj.bmjjournals.com/cgi/content/full/333/7557/44

HSL6703
Litch B.
Forming unique partnerships. The healthy eating message moves from classroom to clinic.
Healthc Exec 2006 Jul-Aug 01;21(4):44-6

HSL6734
Ramiah I, Reich MR.
Building effective public-private partnerships: experiences and lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP).
Soc Sci Med 2006 Jul 01;63(2):397-408
Link to source with long URL

HSL6778
Kesselman I, Elstein D, Israeli A, Chertkoff R, Zimran A.
National health budgets for expensive orphan drugs: Gaucher disease in Israel as a model.
Blood Cells Mol Dis 2006 Jul-Aug 01;37(1):46-9
Link to source with long URL

HSL6806
Milstien JB, Kaddar M, Kieny MP.
The impact of globalization on vaccine development and availability.
Health Aff (Millwood) 2006 Jul-Aug 01;25(4):1061-9
http://content.healthaffairs.org/cgi/content/full/25/4/1061

HSL6807
Ohno Y, Kusama M, Hisaka A, Yanagihara Y, Suzuki H.
Analysis of pharmacokinetic data provided in Japanese package inserts and interview forms focusing on urinary excretion of pharmacologically active species.
Yakugaku Zasshi 2006 Jul 01;126(7):489-94
http://www.jstage.jst.go.jp/article/yakushi/126/7/126_489/_article

HSL6494
Polak M.
Viewpoint: megatrials and the development of antithrombotics.
Circulation 2006 Jun 27;113(25):f97
http://circ.ahajournals.org/cgi/reprint/113/25/f97

HSL5941
Barclay L, Vega C.
Anti-inflammatory Drugs Increase Mortality After Previous Myocardial Infarction
Medscape 2006 Jun 20
http://www.medscape.com/viewarticle/537002

HSL5723
Moynihan R.
Expanding definitions of obesity may harm children.
BMJ 2006 Jun 17;332(7555):1412
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1412?etoc

HSL5729
Saperia J, Ashby D, Gunnell D.
Suicidal behaviour and SSRIs: updated meta-analysis.
BMJ 2006 Jun 17;332(7555):1453
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1453-a?etoc

HSL5816
Fine PG.
Prescribing placebos
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):377-380
http://www.ama-assn.org/ama/pub/category/16253.html

HSL5484
Tanne JH.
Rofecoxib may cause heart attacks in first weeks of use.
BMJ 2006 May 13;332(7550):1114
http://bmj.com/cgi/content/short/332/7550/1114?etoc

HSL5488
Raven MK.
Depression should be managed like a chronic disease: myth of 15% suicide rate was promulgated again.
BMJ 2006 May 13;332(7550):1154
http://bmj.bmjjournals.com/cgi/content/full/332/7550/1154

HSL6101
Ohbayashi H.
[Results of a survey questionnaire concerning smoking conditions in 54 major Japanese pharmaceutical companies and among their employees].
Nihon Kokyuki Gakkai Zasshi 2006 May 01;44(5):374-83

HSL6220
Brock DW.
How much is more life worth?
Hastings Cent Rep 2006 May-Jun 01;36(3):17-9

HSL6757
Stagnaro JC.
[The discovery of therapeutic properties of lithium].
Vertex 2006 May-Jun 01;17(67):225-30

HSL6113
Sesardic D.
Regulatory considerations on new adjuvants and delivery systems.
Vaccine 2006 Apr 12;24

HSL5706
Davis RL, Khoury MJ.
A public health approach to pharmacogenomics and gene-based diagnostic tests.
Pharmacogenomics 2006 Apr 01;7(3):331-7
http://www.futuremedicine.com/doi/abs/10.2217/14622416.7.3.331

HSL5589
Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R.
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
BMJ 2006 Apr 1;332(7544):756-61
http://bmj.bmjjournals.com/cgi/content/full/332/7544/756

HSL5934
Cooke CE, Hammerash WJ Jr.
Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
Clin Ther 2006 Apr 01;28(4):591-9
Link to source with long URL

HSL6779
Alphs L.
An industry perspective on the NIMH consensus statement on negative symptoms.
Schizophr Bull 2006 Apr 01;32(2):225-30
http://schizophreniabulletin.oxfordjournals.org/cgi/content/full/32/2/225

HSL5494
Boyce P.
Restoring wisdom to the practice of psychiatry.
Australas Psychiatry 2006 Mar 01;14(1):3-7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1665.2006.02241.x

HSL5935
Toure JT, Brandt NJ, Limcangco MR, Briesacher BA.
Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Am J Geriatr Pharmacother 2006 Mar 01;4(1):25-35
Link to source with long URL

HSL5586
Nunnery J, Angulo FJ, Tollefson L.
Public health and policy.
Prev Vet Med 2006 Feb 24;73(2-3):191-5
Link to source with long URL

HSL5273
Andre T, De Gramont A.
[A good cooperation between industry and French medical oncologists]
Bull Cancer. 2006 Feb 01;93(Supp 1):S3-4
Link to source with long URL

HSL5757
Goldstein S.
Is ADHD a growth industry?
J Atten Disord 2006 Feb 01;9(3):461-4
http://jad.sagepub.com/cgi/reprint/9/3/461

HSL5433
MacLennan AH, Sturdee DW.
The 'bioidentical/bioequivalent' hormone scam.
Climacteric 2006 Feb;9(1):1-3

HSL5495
Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, Markides K.
Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study.
J Gerontol A Biol Sci Med Sci 2006 Feb;61(2):170-5
http://biomed.gerontologyjournals.org/cgi/content/full/61/2/170

HSL5573
Genuis SK, Genuis SJ.
Exploring the continuum: medical information to effective clinical practice. Paper I: the translation of knowledge into clinical practice.
J Eval Clin Pract 2006 Feb;12(1):49-62
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2005.00609.x

HSL5339
Harris G.
In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
NY Times (Print) 2006 Jan 25;A14

HSL5236
Clarke JT.
Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy.
CMAJ 2006 Jan 17;174(2):189-90
http://www.cmaj.ca/cgi/content/full/174/2/189

HSL5434
Wolfson W.
Holding back the tide of antibiotic resistance.
Chem Biol 2006 Jan 01;13(1):1-3
http://linkinghub.elsevier.com/retrieve/pii/S1074-5521(06)00005-6

HSL6208
Chur-Hansen A, Zion D.
'Let's fix the chemical imbalance first, and then we can work on the problems second': an exploration of ethical implications of prescribing an SSRI for 'depression'.
Monash Bioeth Rev 2006 Jan 01;25(1):15-30

HSL5362
Pfizer and Humana join forces on new Medicare Health Support Program.
Dis Manag Advis 2006 Jan;12(1):8-9,

HSL5124
Seeman N, Brown AD.
Remembering Peter Drucker: inspiring the quality revolution in healthcare.
Healthc Q 2006;9(1):50-2,

HSL5398
Hasman A, Holm S.
Direct-to-consumer advertising: should there be a free market in healthcare information?
Camb Q Healthc Ethics 2006 Win;15(1):42-9

HSL6104
Campo S, Cameron KA.
Differential effects of exposure to social norms campaigns: a cause for concern.
Health Commun 2006;19(3):209-19
http://www.leaonline.com/doi/abs/10.1207/s15327027hc1903_3

HSL6731
Hullett CR.
Using functional theory to promote HIV testing: the impact of value-expressive messages, uncertainty, and fear.
Health Commun 2006;20(1):57-67
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_6

HSL6794
Roller ST, Voorhees T Jr, Lunkenheimer AK.
Obesity, food marketing and consumer litigation: threat or opportunity?
Food Drug Law J 2006;61(3):419-44

HSL6930
Oh R, Beresford S, Lafferty W.
The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and 3 Fatty Acid Prescribing Behaviors
J Am Board Fam Med. 2006;19(5):459-467
http://www.medscape.com/viewarticle/545407

HSL3794
Barker R.
New ABPI code provides more information for patients.
BMJ 2005 Dec 10;331(7529):1409
Link to source with long URL

HSL5218
Silk KJ, Weiner J, Parrott RL.
Gene cuisine or Frankenfood? The theory of reasoned action as an audience segmentation strategy for messages about genetically modified foods.
J Health Commun 2005 Dec;10(8):751-67
Link to source with long URL

HSL5297
Cagle GD.
Fostering partnerships: an industry perspective.
Retina 2005 Dec;25(8)
Link to source with long URL

HSL5299
Kaplan LJ.
Attracting pharmaceutical companies as partners in drug development.
Retina 2005 Dec;25(8)
Link to source with long URL

HSL5047
Green MD.
Causation, Vioxx, and legal issues.
Science 2005 Nov 11;310(5750):973
Link to source with long URL

HSL5445
Small DH.
Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?
Expert Opin Emerg Drugs 2005 Nov 01;10(4):817-25
Link to source with long URL

HSL5222
Kirkwood L.
An artist's perspective on body image, the media, and contemporary society.
J Nutr Educ Behav 2005 Nov-Dec;37

HSL5250
Menaster MJ.
Weight gain, sexual dysfunction, and bupropion.
J Clin Psychiatry 2005 Oct;66(10):1335-6
http://article.psychiatrist.com/?ContentType=START&ID=10001489

HSL5267
Couzos S.
PBS medications--improving access for Aboriginal and Torres Strait Islander peoples.
Aust Fam Physician 2005 Oct;34(10):841-4
http://www.racgp.org.au/document.asp?id=18314

HSL2846
Eaton L.
BMA warns against unnecessary screening tests in private sector.
BMJ 2005 Sep 3;331(7515):475
http://bmj.bmjjournals.com/cgi/content/full/331/7515/475-b

HSL4052
Havlir DV, Hammer SMPatents versus patients.
Antiretroviral therapy in India?
N Engl J Med 2005 Aug 25;353(8):749-51
http://content.nejm.org/cgi/content/extract/353/8/749

HSL2843
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW.
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.
JAMA 2005 Aug 10;294(6):716-24
http://jama.ama-assn.org/cgi/content/full/294/6/716

HSL5390
Honebrink A.
Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.
Expert Opin Emerg Drugs 2005 Aug;10(3):619-41
Link to source with long URL

HSL2645
Gleason PP, Williams C, Hrdy S, Hartwig SC, Lassen D.
Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program.
Pharmacotherapy 2005 Jul;25(7):924-34
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed

HSL4206
Taylor JP, Evers S, McKenna M.
Determinants of healthy eating in children and youth.
Can J Public Health 2005 Jul-Aug;96

HSL5304
Wertheimer AI, Santella TM.
Counterfeit drugs: defining the problem and finding solutions.
Expert Opin Drug Saf 2005 Jul;4(4):619-22
Link to source with long URL

HSL1911
Mandel M.
Smokin' family feud: Michele Mandel visits the home of the Kaczmarczyks. He's on a hunger strike because she won't quit smoking
The Toronto Sun 2005 Jun 12

HSL1913
Health Canada to receive FDA award
CNW Telbec 2005 Jun 10

HSL1905
Levin M.
Firm Removed Mercury From Nasal Spray, Not Infant Shots: Wyeth used thimerosal in vaccines for years after it did away with the chemical in Dristan.
The LA Times 2005 Jun 4

HSL1978
Stocks N, Allan J, Mansfield PR.
Management of hyperlipidaemia.
Aust Fam Physician 2005 Jun;34(6):447-53
http://www.racgp.org.au/document.asp?id=17049

HSL4058
Bateman C.
Government 'encouraging snake-oil salesman' Rath.
S Afr Med J 2005 Jun 01;95(6):372,
Link to source with long URL

HSL4246
Denneboom W, Dautzenberg MG, Grol R, De Smet PA.
User-related pharmaceutical care problems and factors affecting them: the importance of clinical relevance.
J Clin Pharm Ther 2005 Jun 01;30(3):215-23
Link to source with long URL

HSL4208
Stern SR.
Messages from teens on the big screen: smoking, drinking, and drug use in teen-centered films.
J Health Commun 2005 Jun;10(4):331-46
Link to source with long URL

HSL1868
Msnbc .
U.S. suicides decline, but thoughts remain: Vulnerable patients need better treatment, experts say
Reuters 2005 May 24

HSL5450
Dallegri F, Bertolotto M, Ottonello L.
A review of the emerging profile of the anti-inflammatory drug oxaprozin.
Expert Opin Pharmacother 2005 May 01;6(5):777-85
Link to source with long URL

HSL5451
Wurm P, De Caestecker J.
Emerging drugs for gastro-oesophageal reflux disease.
Expert Opin Emerg Drugs 2005 May 01;10(2):457-71
http://www.expertopin.com/doi/abs/10.1517/14728214.10.2.457

HSL5454
Kelland LR.
Emerging drugs for ovarian cancer.
Expert Opin Emerg Drugs 2005 May 01;10(2):413-24
Link to source with long URL

HSL5457
Silay YS, Jankovic J.
Emerging drugs in Tourette syndrome.
Expert Opin Emerg Drugs 2005 May 01;10(2):365-80
http://www.expertopin.com/doi/abs/10.1517/14728214.10.2.365

HSL5458
Ryu H, Ferrante RJ.
Emerging chemotherapeutic strategies for Huntington's disease.
Expert Opin Emerg Drugs 2005 May 01;10(2):345-63
Link to source with long URL

HSL5459
Litten RZ, Fertig J, Mattson M, Egli M.
Development of medications for alcohol use disorders: recent advances and ongoing challenges.
Expert Opin Emerg Drugs 2005 May 01;10(2):323-43
http://www.expertopin.com/doi/abs/10.1517/14728214.10.2.323

HSL2482
Doucette WR, Andersen TN.
Practitioner activities in patient education and drug therapy monitoring for community dwelling elderly patients.
Patient Educ Couns 2005 May;57(2):204-10
Link to source with long URL

HSL1920
Offit PA.
Why are pharmaceutical companies gradually abandoning vaccines?
Health Aff (Millwood) 2005 May-Jun;24(3):622-30
http://content.healthaffairs.org/cgi/content/full/24/3/622

HSL6144
Shann F.
Non-specific effects of vaccination: vaccines have non-specific (heterologous) effects.
BMJ 2005 Apr 9;330(7495):844
http://bmj.bmjjournals.com/cgi/content/full/330/7495/844

HSL5035
Morgan S, Bassett KL, Wright JM, Yan L.
First-line first? Trends in thiazide prescribing for hypertensive seniors
PLoS Med 2005 Apr 00;2(4)
Link to source with long URL

HSL4210
Macias W, Lewis LS, Smith TL.
Health-related message boards/chat rooms on the Web: discussion content and implications for pharmaceutical sponsorships.
J Health Commun 2005 Apr-May;10(3):209-23
Link to source with long URL

HSL2654
De Bruin ML, Pettersson M, Meyboom RH, Hoes AW, Leufkens HG.
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
Eur Heart J 2005 Mar;26(6):590-7
http://eurheartj.oxfordjournals.org/cgi/content/full/26/6/590

HSL6613
Earle L, Kelly L.
Coping strategies, depression, and anxiety among Ontario family medicine residents.
Can Fam Physician 2005 Feb 01;51:242-3
Link to source with long URL

HSL5215
Kagan J.
Human morality and temperament.
Nebr Symp Motiv 2005;51:1-32

HSL5245
Abrahams E, Ginsburg GS, Silver M.
The Personalized Medicine Coalition: goals and strategies.
Am J Pharmacogenomics 2005;5(6):345-55

HSL5392
Caplan A, Elliott C.
Is it ethical to use enhancement technologies to make us better than well?
PLoS Med 2004 Dec;1(3):e52
Link to source with long URL

HSL5255
Bensley RJ, Mercer N, Brusk JJ, Underhile R, Rivas J, Anderson J, Kelleher D, Lupella M, de Jager AC.
The eHealth Behavior Management Model: a stage-based approach to behavior change and management.
Prev Chronic Dis 2004 Oct;1(4):A14
Link to source with long URL

HSL2091
Andrews E, Dombeck M.
The role of scientific evidence of risks and benefits in determining risk management policies for medications.
Pharmacoepidemiol Drug Saf 2004 Sep;13(9):599-608
http://www3.interscience.wiley.com/cgi-bin/abstract/105560406/ABSTRACT

HSL2819
Romero CE, Baron JD, Knox AP, Hinchey JA, Ropper AH.
Barbiturate withdrawal following Internet purchase of Fioricet.
Arch Neurol 2004 Jul;61(7):1111-2
http://archneur.ama-assn.org/cgi/content/full/61/7/1111

HSL2085
Bojo Canales C, Carabantes Alarcon D, Veiga de Cabo J, Martinez Hernandez D.
[Bibliometric analysis of the Spanish Journal of Chemotherapy (1996-2000)]
Rev Esp Quimioterap 2004 Jun 01;17(2):161-8
http://www.seq.es/seq/0214-3429/17/2/161.pdf

HSL2079
Caudill-Slosberg MA, Schwartz LM, Woloshin S.
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000.
Pain 2004 Jun;109(3):514-9
http://linkinghub.elsevier.com/retrieve/pii/S0304395904001307

HSL231
Mayor S.
Cardiovascular disease threatens developing countries.
BMJ 2004 May 1;328(7447):1032
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036

HSL1368
Sorensen TD, Song J, Westberg SM.
The limitation of good intentions: prescribing medications for the uninsured.
J Health Care Poor Underserved 2004 May;15(2):152-60

HSL2806
Landers SH, AR.
Health care lobbying in the United States
Am J Med 2004 Apr;116(7):474-7

HSL2794
Jorgensen KJ, Gotzsche PC.
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.
BMJ 2004 Jan 17;328(7432):148
http://bmj.bmjjournals.com/cgi/content/full/328/7432/148

HSL2696
Hemminki E, Karttunen T, Hovi SL, Karro H.
The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
Soc Sci Med 2004 Jan;58(1):89-97
Link to source with long URL

HSL1361
Szetela AM.
The relationship between health care and mass media in Polish law.
Med Law 2004;23(1):9-17

HSL2800
Green CJ, Kazanjian A, Helmer D.
Informing, advising, or persuading? An assessment of bone mineral density testing information from consumer health websites
Int J Technol Assess Health Care. 2004 Spring;20(2): 2004 Spr;20(2):156-66

HSL5256
Tett SE.
A perspective on Australia's National Medicines Policy.
Can J Clin Pharmacol 2004 Spr;11(1):e28-38
Link to source with long URL

HSL5869
Dunning D, Heath C, Suls JM.
Flawed self-assessment: implications for education and the workplace.
Psychol Sci Public Interest 2004;5:69-106

HSL1409
Mechanic D.
Is the prevalence of mental disorders a good measure of the need for services?
Health Aff (Millwood) 2003 Sep-Oct;22(5):8-20
http://content.healthaffairs.org/cgi/pmidlookup?view=long&pmid=14515877

HSL1454
Coleman B.
Producing an information leaflet to help patients access high quality drug information on the Internet: a local study.
Health Info Libr J 2003 Sep;20(3):160-71
Link to source with long URL

HSL5707
Berwick DM.
Disseminating innovations in health care.
JAMA 2003 Apr 16;289(15):1969-75
http://jama.ama-assn.org/cgi/content/full/289/15/1969

HSL5957
Helgason T, Tomasson K, Zoega T.
[Prevalence and distribution of antidepressant, anxiolytic and hypnotic use in 2001].
Laeknabladid 2003 Jan 01;89(1):15-22

HSL1414
Manima A.
Ethical issues in palliative care: considerations.
J Pain Palliat Care Pharmacother 2003;17(3-4):141-9;

HSL2902
Bessell TL, Silagy CA, Anderson JN, Hiller JE, Sansom LN.
Quality of global e-pharmacies: can we safeguard consumers?
Eur J Clin Pharmacol 2002 Dec;58(9):567-72
Link to source with long URL

HSL5863
Coast J, Smith R, Karcher AM, Wilton P, Millar M.
Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
Health Econ 2002 Oct 01;11(7):637-47
http://www3.interscience.wiley.com/cgi-bin/abstract/93521364/ABSTRACT

HSL2298
Pinkus RL.
From Lydia Pinkham to Bob Dole: what the changing face of direct-to-consumer drug advertising reveals about the professionalism of medicine.
Kennedy Inst Ethics J 2002 Jun;12(2):141-58
Link to source with long URL

HSL6211
Herlihyj , Gandy , J
Causation and explanation
The Psychologist 2002 May 1;15(5):248-251

HSL2246
Vlasov VV.
[Emerging problems of medical ethics in Russia: medical practice and research]
Kardiologiia. 2002;42(5):81-4. 2002;42(5):81-4
Link to source with long URL

HSL5440
Jesani A.
Calls for advertising and market reforms in health care.
Issues Med Ethics 2001 Jan-Mar;9(1):19

HSL5516
McGhan WF.
Employer and consumer perspectives.
Value Health 1998 Nov 01;1(4):237-42
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1524-4733.1998.140237.x

HSL4222
Tremayne WH.
Dollars & sense of the health care industry.
N J Med 1998 May 01;95(5):71-3

HSL726
Dukes MN.
The menopause and the pharmaceutical industry.
J Psychosom Obstet Gynaecol 1997 Jun;18(2):181-8

HSL849
Gruber W, Llewelyn J, Arras C, Lion S.
The role of the pharmaceutical industry in promoting patient education.
Patient Educ Couns 1995 Sep;26(1-3):245-9

HSL2721
Shorr RI, Greene WL.
A food-borne outbreak of expensive antibiotic use in a community teaching hospital.
JAMA 1995 Jun 28;273(24):1908
Link to source with long URL

HSL5972
Naimark D, Naglie G, Detsky AS.
The meaning of life expectancy: what is a clinically significant gain?
J Gen Intern Med 1994 Dec 01;9(12):702-7

HSL6286
Chirac P.
Control of drug advertising in France: a poor example
Prescrire International 1994;3(13):145-147

HSL1899
Kligman M, Culver CM.
An analysis of interpersonal manipulation.
J Med Philos 1992 Apr;17(2):173-97

HSL4686
Moser M, Blaufox MD, Freis E, Gifford RW Jr, Kirkendall W, Langford H, Shapiro A, Sheps S.
Who really determines your patients' prescriptions?
JAMA 1991 Jan 23-30;265(4):498-500
Link to source with long URL

HSL4659
Goihman-yahr M.
Editorial comment [response to Dominguez-Soto (1991)]
International Journal of Dermatology 1991;30(2):149

HSL4001
Hawkins JW, Aber CS.
The content of advertisements in medical journals: distorting the image of women.
Women Health 1988;14(2):43-59

HSL3978
Re: the promotion of lincomycin and clindamycin
1987 Oct

HSL3964
MaLAM letter follow up—Janssen
MaLAM Newsletter 1987 Jun:1-2

HSL3957
Re: the promotion of co-dergocrine
1987 Feb

HSL2729
Willams P.
Sound Impressions
Pharmaceutical Executive. 1985 Jun:58-59
Nil

HSL3739
Kunin CM.
The responsibility of the infectious disease community for the optimal use of antimicrobial agents.
J Infect Dis 1985 Mar;151(3):388-98

HSL3608
Re: the promotion of products containing amidopyrine
1983 Nov

HSL3525
Drug and Therapeutics Bulletin
British Journal of Hospital Medicine 1981;25:309

HSL3526
Turner P.
Drug and Therapeutics Bulletin
Drug and Therapeutics Bulletin 1981;25:309

HSL3434
Miller JA, Waller R.
Health care advertising: consumer vs. physician attitudes
Journal of Advertising 1979;8(4):20-29

HSL3390
Green B.
The politics of psychoactive drug use in old age.
Gerontologist 1978 Dec;18(6):525-30

HSL3210
Usdin G.
The coin needn't smell: A response to the Seidenberg thesis
Mental Hygiene 1971 Jan;55:32-35

947 visits to this page since 1 January 2007